Content » Vol 93, Issue 4

Letter to the Editor

Two Cases of Hand, Foot, and Mouth Disease Involving the Scalp

Ann Sophie Lønnberg1, Jesper Elberling1, Thea K. Fischer2 and Lone Skov1

1Department of Dermato-Allergology, Gentofte Hospital, University of Copenhagen, Niels Andersens Vej 65, DK-2900 Copenhagen, and 2Department of Virology, Statens Serum Institut, Copenhagen, Denmark. E-mail: lone.skov.02@regionh.dk

Accepted September 24, 2012.

Hand, foot, and mouth disease (HFMD), as the name indicates, affects the hands, feet and mouth, with haemorrhagic and papulo-vesicular lesions (1).

HFMD is generally a mild and self-limited disease caused by enteroviruses, primarily strains of coxsackieviruses, A10 and A16, and enterovirus 71. Enteroviruses are small, non-enveloped, single-stranded RNA viruses that belong to the family Picornaviridae (2).

HFMD is a highly contagious disease occurring most commonly in children below the age of 5 years (1, 3). Small epidemics of HFMDs are seen in nursery schools or kindergartens, usually during the summer and autumn months. Several major outbreaks have been described throughout the world, especially in Asia (2, 4).

We describe here 2 cases of HFMD in adults. In addition to presenting typical lesions on the hands and feet, both cases had involvement of the scalp, which is unusual, and no lesions in the oral mucosa where lesions are most commonly found.

CASE REPORTs

Case 1.

A 49-year-old man with a 2-day history of multiple painful haemorrhagic papules and vesicles in the palms, soles, face and scalp (Fig. 1). The oral cavity was spared. Two days prior to the cutaneous lesions the patient had had fever and malaise. The patient denied known exposure to HFMD. His medical history included diabetes type II and hypertension.

3839fig1.tif

Fig. 1. The scalp of patient 1 showing several papules and vesicles.

Laboratory findings revealed increased C-reactive protein, 56 mg/l (normal limits: < 5 mg/l), and a complete blood count within normal limits. Enterovirus RNA was detected by real-time PCR, and coxsackievirus A6 (CV A6) subtype was identified by semi-nested reverse transcriptase (RT) PCR and sequencing. Histological examination from a 3-mm punch biopsy of another vesicle was consistent with post-viral dermatosis, confirming the diagnosis of HFMD.

Case 2.

A 37-year-old woman presented with multiple vesicles on the palms, soles, scalp and genital area. The oral cavity was not affected. She had a history of a fever and sore throat 2 days prior to the skin lesions. There had recently been an outbreak of HFMD in her child’s kindergarten. She had no past history of medical problems.

A widespread vesicular eruption on the scalp was initially interpreted as secondary bacterial infection and the patient was treated with oral antibiotics. No pathogenic bacteria were cultivated from a swab specimen.

Histological examination of a 3-mm punch biopsy suggested an enterovirus infection, and enterovirus RNA was identified in vesicular fluid by real-time PCR. The subtype CV A6 was subsequently identified by sequencing the semi-nested RT-PCR product.

DISCUSSION

These 2 cases are not typical presentations of HFMD. Firstly, the causative agent was CV A6, a virus that recently has only been associated with HFMD in Scandinavia (5, 6). Secondly, the location of the cutaneous lesions to the scalp has to our knowledge not been described previously in HFMD.

Oral lesions are the most common anatomical location, followed by the hands and feet. Patients do not need to have manifestations in all 3 areas to be classified as having HFMD. Cases with symptoms elsewhere, primarily on the buttocks and limbs, have also been described (1, 3, 4, 7). Other typical clinical findings are fever, malaise, abdominal pain and upper respiratory tract symptoms (1, 4, 8, 9).

CV A6 is not one of the usual causes of HFMD; the serotype is more often associated with herpangina, in which the ulcerative lesions are predominantly located on posterior oropharyngeal structures (1, 3, 4). Single cases of both immunocompetent and immunocompromised adults with HFMD caused by CV A6 have been described (3, 11, 12 ). Furthermore, within the last 2 years outbreaks of HFMD caused by CV A6 have been reported in the USA, Japan and Europe (5–7, 9, 10). McIntyre et al. (10) found that 24% of their patients were adults, of whom the majority had had a record of exposure to a childcare facility or school.

HFMD spreads through contact with salvia, respiratory secretions, fluid in vesicles, and faeces. Hygiene precautions are important to reduce transmission. For diagnosis of enterovirus the timesaving and sensitive PCR technique is preferred to viral culture (2, 8).

Differential diagnosis of HFMD in the 2 cases described here included drug eruptions, erythema multiforme, vasculitis, dermatitis, bacterial infections, herpes, and varicella. Awareness, that papulo-vesicular scalp lesions may be part of the clinical presentation of HFMD might improve future diagnosis and surveillance of HFMD.

The authors declare no conflicts of interest.

REFERENCES

1. Wolff K, Goldsmith LA, Katz SI, Gilchrest B, Paller A, Leffell D (editors). Fitzpatrick’s dermatology in general medicine. Vol. 2. Seventh edition. New York: The McGraw-Hill companies, Inc.; 2007, p. 1868–1869.

2. Stalkup JR, Chilukuri S. Enterovirus infections: a review of clinical presentation, diagnosis, and treatment. Dermatol Clin 2002; 20: 217–223.

3. Chatproedprai S, Theanboonlers A, Korkong S, Thongmee C, Wananukul S, Poovorawan Y. Clinical and molecular characterizations of hand-foot-and-mouth disease in Thailand, 2008-2009. Jpn J Infect Dis 2010; 63: 229–233.

4. Ma E, Lam T, Chan KC, Wong C, Chuang SK. Changing epidemiology of hand, foot, and mouth disease in Hong Kong, 2001–2009. Jpn J Infect Dis 2010; 63: 422–426.

5. Blomqvist S, Klemola P, Kaijalainen S, Paananen A, Simonen ML, Vuorinen T, et al. Co-circulation of coxsackieviruses A6 and A10 in hand, foot and mouth disease outbreak in Finland. Clin Virol 2010; 48: 49–54.

6. Osterback R, Vuorinen T, Linna M, Susi P, Hyypiä T, Waris M. Coxsackievirus A6 and hand, foot, and mouth disease, Finland. Emerg Infect Dis 2009; 15: 1485–1488.

7. Fujimoto T, Iizuka S, Enomoto M, Abe K, Yamashita K, Hanaoka N, et al. Hand, foot, and mouth disease caused by coxsackievirus A6, Japan, 2011. Emerg Infect Dis 2012; 18: 337–339.

8. Chang LY, Lin TY, Huang YC, Tsao KC, Shih SR, Kuo ML, et al. Comparison of enterovirus 71 and coxsackievirus A16 clinical illnesses during the taiwan enterovirus epidemic, 1998. Pediatr Infect Dis J 1999; 18: 1092–1096.

9. Mirand A, Henquell C, Archimbaud C, Ughetto S, Antona D, Bailly JL, et al. Outbreak of hand, foot and mouth disease/herpangina associated with coxsackievirus A6 and A10 infections in 2010, France: a large citywide prospective observational study. Clin Microbiol Infect 2012; 18: E110–E118.

10. McIntyre MG, Stevens KM, Davidson S, Pippin T, Magill D, Kulhanjian JA, et al. Notes from the field: severe hand, foot, and mouth disease associated with coxsackievirus A6 – Alabama, Connecticut, California, and Nevada, November 2011 – February 2012. MMWR Morb Mortal Wkly Rep 2012; 16: 213–214.

11. Shin JU, Oh SH, Lee JH. A case of hand-foot-mouth disease in immunocompetent adult. Ann Dermatol 2010; 22: 216–218.

12. Faulkner CF, Godbolt AM, DeAmbrosis B, Triscott J. Hand, foot and mouth disease in an immunocompromised adult treated with aciclovir. Australas J Dermatol 2003; 44: 203–206.